PhenomeX (CELL) Cash From Financing

CELL Annual CFF

$9.68 M
-$3.96 M-29.06%

01 December 2022

CELL Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CELL Quarterly CFF

-$70.73 M
-$119.73 M-244.37%

01 June 2023

CELL Quarterly CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CELL TTM CFF

-$13.44 M
-$71.09 M-123.31%

01 June 2023

CELL TTM CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CELL Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-29.1%-10000.0%-375.9%
3 y3 years+846.9%-10000.0%-1289.3%
5 y5 years-89.9%-10000.0%-1415.0%

CELL Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time-94.9%-137.1%-106.7%

PhenomeX Cash From Financing History

DateAnnualQuarterlyTTM
June 2023
-
-$70.73 M(-244.4%)
-$13.44 M(-123.3%)
Mar 2023
-
$48.99 M(+503.0%)
$57.65 M(+495.7%)
Dec 2022
$9.68 M(-29.1%)
$8.13 M(+4516.5%)
$9.68 M(+344.9%)
Sept 2022
-
$176.00 K(-50.3%)
$2.17 M(-55.3%)
June 2022
-
$354.00 K(-65.4%)
$4.87 M(-20.7%)
Mar 2022
-
$1.02 M(+64.0%)
$6.14 M(-55.0%)
Dec 2021
$13.64 M
$623.00 K(-78.3%)
$13.64 M(+0.9%)
Sept 2021
-
$2.87 M(+76.5%)
$13.52 M(-93.3%)
June 2021
-
$1.63 M(-80.9%)
$201.23 M(+0.6%)
DateAnnualQuarterlyTTM
Mar 2021
-
$8.52 M(+1597.0%)
$200.01 M(+4.4%)
Dec 2020
$191.52 M(>+9900.0%)
$502.00 K(-99.7%)
$191.52 M(+0.2%)
Sept 2020
-
$190.58 M(>+9900.0%)
$191.13 M(>+9900.0%)
June 2020
-
$411.00 K(+1857.1%)
$1.13 M(+36.8%)
Mar 2020
-
$21.00 K(-82.6%)
$826.00 K(-19.2%)
Dec 2019
$1.02 M(-98.9%)
$121.00 K(-79.0%)
$1.02 M(+13.4%)
Sept 2019
-
$577.00 K(+439.3%)
$901.00 K(+178.1%)
June 2019
-
$107.00 K(-50.7%)
$324.00 K(+49.3%)
Mar 2019
-
$217.00 K
$217.00 K
Dec 2018
$95.56 M
-
-

FAQ

  • What is PhenomeX annual cash flow from financing activities?
  • What is the all time high annual CFF for PhenomeX?
  • What is PhenomeX annual CFF year-on-year change?
  • What is PhenomeX quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for PhenomeX?
  • What is PhenomeX quarterly CFF year-on-year change?
  • What is PhenomeX TTM cash flow from financing activities?
  • What is the all time high TTM CFF for PhenomeX?
  • What is PhenomeX TTM CFF year-on-year change?

What is PhenomeX annual cash flow from financing activities?

The current annual CFF of CELL is $9.68 M

What is the all time high annual CFF for PhenomeX?

PhenomeX all-time high annual cash flow from financing activities is $191.52 M

What is PhenomeX annual CFF year-on-year change?

Over the past year, CELL annual cash flow from financing activities has changed by -$3.96 M (-29.06%)

What is PhenomeX quarterly cash flow from financing activities?

The current quarterly CFF of CELL is -$70.73 M

What is the all time high quarterly CFF for PhenomeX?

PhenomeX all-time high quarterly cash flow from financing activities is $190.58 M

What is PhenomeX quarterly CFF year-on-year change?

Over the past year, CELL quarterly cash flow from financing activities has changed by -$71.09 M (-20081.64%)

What is PhenomeX TTM cash flow from financing activities?

The current TTM CFF of CELL is -$13.44 M

What is the all time high TTM CFF for PhenomeX?

PhenomeX all-time high TTM cash flow from financing activities is $201.23 M

What is PhenomeX TTM CFF year-on-year change?

Over the past year, CELL TTM cash flow from financing activities has changed by -$18.31 M (-375.90%)